Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
The biology of incretin hormones
Patients should not attempt to accelerate dose increases independently, as this significantly raises the risk of adverse effects including nausea, vomiting, and gastrointestinal discomfort
Example conceptual model: While this approach has not yet been validated in large clinical trials, it reflects the idea that metabolic response may scale with body mass and lean tissue metabolism
Yes, protein digestion releases amino acids that stimulate GLP-1 secretion in the gut